Literature DB >> 26383518

A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?

Alireza Mirzaei1, Gholamreza Tavoosidana2, Afshin Abdi Rad3, Farhad Rezaei4, Masoumeh Tavakoli-Yaraki5, Azade Amini Kadijani6, Ehsan Khalili7, Zahra Madjd8,9.   

Abstract

Cancer stem cell (CSC) markers could serve as potential prognostic procedure. This study is aimed to investigate the local expression of doublecortin-like kinase 1 (DCLK1) and Lgr5 in colorectal cancer tissues (CRC) at both protein and messenger RNA (mRNA) level, followed by providing a comparison of the local and circulating expression pattern of these markers, based on our present and previous study. The mRNA expression level of DCLK1 and Lgr5 was evaluated using comparative real-time PCR method applying 58 fresh tumor tissues and their correspondent normal margins. Immunohistochemistry was applied to analyze the protein expression level of DCLK1 and Lgr5 in paraffin-embedded CRC tissues. The correlation of DCLK1 and Lgr5 expression pattern with clinicopathological characteristics was assessed. A higher mRNA expression level of DCLK1 (3.28-fold change, p < 0.001) and Lgr5 (2.29-fold change, p < 0.001) was observed in CRC fresh tissues compared to the normal adjacent margins, and the expression level was higher in patients with higher grade and stages of disease and patients who underwent neoadjuvant chemoradiotherapy (CRT). The protein expression level of DCLK1 and Lgr5 was also increased significantly in tumor tissues compared to normal colon tissues which were positively correlated to tumor stage and grade and neoadjuvant CRT. Taken together, the results of protein analysis were in accordance with mRNA assessment. The local expression pattern of DCLK1 and Lgr5 was also in accordance with their expression level in circulation. However, some minor inconsistencies were observed which may be attributed to several factors including the possible effect of CRT on CSC reprogramming.

Entities:  

Keywords:  Circulating cancer stem cell; Colorectal cancer; DCLK1; Lgr5; Local cancer stem cell

Mesh:

Substances:

Year:  2015        PMID: 26383518     DOI: 10.1007/s13277-015-3989-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  53 in total

1.  Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.

Authors:  Alireza Mirzaei; Gholamreza Tavoosidana; Mohammad Hossein Modarressi; Afshin Abdi Rad; Mohammad Sadegh Fazeli; Reza Shirkoohi; Masoumeh Tavakoli-Yaraki; Zahra Madjd
Journal:  Tumour Biol       Date:  2015-01-29

2.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

Review 3.  Tumor heterogeneity: causes and consequences.

Authors:  Andriy Marusyk; Kornelia Polyak
Journal:  Biochim Biophys Acta       Date:  2009-11-18

Review 4.  Markers in normal and cancer stem cells.

Authors:  Thanemozhi G Natarajan; Kevin T FitzGerald
Journal:  Cancer Biomark       Date:  2007       Impact factor: 4.388

5.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

6.  Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.

Authors:  Arnout G Schepers; Hugo J Snippert; Daniel E Stange; Maaike van den Born; Johan H van Es; Marc van de Wetering; Hans Clevers
Journal:  Science       Date:  2012-08-01       Impact factor: 47.728

7.  A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.

Authors:  S Detre; G Saclani Jotti; M Dowsett
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

8.  Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.

Authors:  Xiao-Song Wu; Hong-Qing Xi; Lin Chen
Journal:  World J Surg Oncol       Date:  2012-11-15       Impact factor: 2.754

9.  Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.

Authors:  Lei Wang; Xing Huang; Xinmin Zheng; Xinghuan Wang; Shiwen Li; Lin Zhang; Zhonghua Yang; Zhiping Xia
Journal:  Int J Biol Sci       Date:  2013-05-15       Impact factor: 6.580

10.  Liver cancer stem cells are selectively enriched by low-dose cisplatin.

Authors:  H Zhang; W J Chang; X Y Li; N Zhang; J J Kong; Y F Wang
Journal:  Braz J Med Biol Res       Date:  2014-04-25       Impact factor: 2.590

View more
  15 in total

1.  Human circulating and tissue gastric cancer stem cells display distinct epithelial-mesenchymal features and behaviors.

Authors:  Shengliang Zhang; Yanna Shang; Tie Chen; Xin Zhou; Wengtong Meng; Chuanwen Fan; Ran Lu; Qiaorong Huang; Xue Li; Xu Hong; Zongguang Zhou; Jiankun Hu; Xianming Mo
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-20       Impact factor: 4.553

2.  Expression pattern and clinical significance of β-catenin gene and protein in patients with primary malignant and benign bone tumors.

Authors:  Narges Khademian; Alireza Mirzaei; Ameinh Hosseini; Leila Zare; Shima Nazem; Pegah Babaheidarian; Alireza Sheikhi; Zohreh Abdolvahabi; Mostafa Ibrahimi; Khodamorad Jamshidi; Mahtab Rahbar; Vahid Salimi; Masoumeh Tavakoli-Yaraki
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

Review 3.  Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis.

Authors:  Elham Kalantari; Mahdieh Razmi; Fatemeh Tajik; Mohsen Asadi-Lari; Roya Ghods; Zahra Madjd
Journal:  Cancer Cell Int       Date:  2022-06-18       Impact factor: 6.429

4.  DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.

Authors:  Tianbo Gao; Min Wang; Lingling Xu; Tao Wen; Jian Liu; Guangyu An
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-12       Impact factor: 4.553

5.  Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas.

Authors:  Farzad Izak Shirian; Mohammad Ghorbani; Mohammad E Khamseh; Mehrnaz Imani; Mahshid Panahi; Alimohammad Alimohammadi; Mitra Nourbakhsh; Vahid Salimi; Masoumeh Tavakoli-Yaraki
Journal:  BMC Endocr Disord       Date:  2021-03-18       Impact factor: 2.763

6.  Properties and feasibility of using cancer stem cells in clinical cancer treatment.

Authors:  Xiao-Mei Gao; Rui Zhang; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

7.  Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment.

Authors:  Vahid Salimi; Zahra Shahsavari; Banafsheh Safizadeh; Ameinh Hosseini; Narges Khademian; Masoumeh Tavakoli-Yaraki
Journal:  Lipids Health Dis       Date:  2017-11-02       Impact factor: 3.876

8.  The local and circulating SOX9 as a potential biomarker for the diagnosis of primary bone cancer.

Authors:  Ameinh Hosseini; Alireza Mirzaei; Vahid Salimi; Khodamorad Jamshidi; Pegah Babaheidarian; Soudabeh Fallah; Zahra Rampisheh; Narges Khademian; Zohreh Abdolvahabi; Mehrdad Bahrabadi; Mostafa Ibrahimi; Fatemeh Hosami; Masoumeh Tavakoli-Yaraki
Journal:  J Bone Oncol       Date:  2020-05-31       Impact factor: 4.072

9.  Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer.

Authors:  Chukwuemeka Ihemelandu; Aisha Naeem; Erika Parasido; Deborah Berry; Krysta Chaldekas; Brent T Harris; Olga Rodriguez; Christopher Albanese
Journal:  Colorectal Cancer       Date:  2019-11-12

10.  Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review.

Authors:  Somayeh Vafaei; Fahimeh Fattahi; Marzieh Ebrahimi; Leila Janani; Ahmad Shariftabrizi; Zahra Madjd
Journal:  Cancer Manag Res       Date:  2019-09-25       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.